Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $5.52 Million - $6.1 Million
-123,600 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $5.58 Million - $6.65 Million
123,600 New
123,600 $5.9 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Twin Securities, Inc. Portfolio

Follow Twin Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Twin Securities, Inc. with notifications on news.